Your session is about to expire
← Back to Search
Behavioral Intervention
Cognitive-Behavioral Therapy for ADHD in College Students (ADHD Trial)
N/A
Recruiting
Led By Mary V. Solanto, Ph.D.
Research Sponsored by Northwell Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline brief-a at 6 months
Awards & highlights
Summary
This trial will help college students with ADHD develop skills to succeed in their studies and avoid negative academic outcomes.
Who is the study for?
This trial is for college students at The City College of New York who have been diagnosed with ADHD, either Inattentive or Combined Subtype. Participants should be in good physical health. It's not open to individuals who are actively suicidal, have certain psychiatric disorders like bipolar disorder or borderline personality disorder, a history of severe childhood trauma, neurological issues, recent drug or alcohol abuse, or any acute psychiatric condition that requires immediate treatment.
What is being tested?
The study is testing a cognitive-behavioral therapy program designed to help college students with ADHD improve their self-management skills. This includes better time management and planning to enhance academic performance and reduce the likelihood of negative educational outcomes.
What are the potential side effects?
Since this trial involves psychological therapy rather than medication, traditional side effects associated with drugs are not expected. However, participants may experience emotional discomfort discussing personal issues during therapy sessions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline aisrs at six months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline aisrs at six months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from Baseline Adult Investigator Symptom Rating Scale (AISRS) at six months
Change from Baseline Behavior Rating Scale of Executive Function - Adult Version (BRIEF-A) at six months
Change from Baseline Learning and Study Strategies Inventory (LASSI) at six months
Trial Design
1Treatment groups
Experimental Treatment
Group I: Cognitive Behavioral Therapy delivered in a group formatExperimental Treatment1 Intervention
Participating students will be assessed before and after the 12-week group Cognitive-Behavioral intervention to ascertain their response to the treatment.
Find a Location
Who is running the clinical trial?
Northwell HealthLead Sponsor
473 Previous Clinical Trials
472,230 Total Patients Enrolled
2 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
525 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
The City College of New YorkOTHER
28 Previous Clinical Trials
6,394 Total Patients Enrolled
Mary V. Solanto, Ph.D.Principal InvestigatorNorthwell Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with borderline personality disorder.I have a neurological disorder like a brain injury, tumor, or Parkinson's.I am in good physical health.I have been diagnosed with a psychotic disorder.I do not have a severe mental health condition that needs immediate treatment over ADHD.I have been diagnosed with ADHD, either inattentive or combined type.I have been diagnosed with bipolar disorder.
Research Study Groups:
This trial has the following groups:- Group 1: Cognitive Behavioral Therapy delivered in a group format
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Attention Deficit Hyperactivity Disorder (ADHD) Patient Testimony for trial: Trial Name: NCT05588505 — N/A
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger